drugset / Trial / NCT00337675

Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED)

NCT00337675

Phase 3 Completed 1771 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a year-long study evaluating the efficacy of both daily and intermittent treatment of asthma in children who experience symptoms episodically (i.e., seasonally, usually in the context of upper respiratory tract infection).

Timeline

Start
2006-10
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Montelukast Other / unclassified 4 mg
Comparator Montelukast Other / unclassified 5 mg

Indications